Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Novartis”
Sponsor: Novartis Pharmaceuticals
Acute Coronary Syndrome
Sponsor: Novartis Pharmaceuticals
Heart Failure With Reduced Ejection Fraction
Romania
Sponsor: Memorial Sloan Kettering Cancer Center
Acute Lymphoblastic Leukemia
United States
Sponsor: M.D. Anderson Cancer Center
Systemic Mastocytosis
United States
Sponsor: Novartis Pharmaceuticals
HR+/HER2- Early Breast Cancer
Saudi Arabia
- RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine CarcinomaCompleted
Sponsor: M.D. Anderson Cancer Center
Neuroendocrine Carcinoma · Islet Cell Carcinoma
United States
- An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and SwedenActive Not Recruiting
Sponsor: Bayer
Multiple Sclerosis (MS)
Finland, Sweden
- Asciminib Roll-over StudyRecruiting
Sponsor: Novartis Pharmaceuticals
Chronic Myelogenous Leukemia · Leukemia, Myelogenous, Chronic, BCR-ABL Positive
United States, Argentina, Austria, Brazil, Bulgaria +24 more
Sponsor: Novartis Pharmaceuticals
Gastroenteropancreatic Neuroendocrine Tumor
United States
Sponsor: Novartis Pharmaceuticals
Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
United States, Argentina, Austria, Belgium, Brazil +14 more
Sponsor: M.D. Anderson Cancer Center
Breast Cancer · Neoplasm Metastasis
United States
Sponsor: Novartis Pharmaceuticals
Schnitzler Syndrome
Japan
Sponsor: Novartis Pharmaceuticals
PIK3CA-Related Overgrowth Spectrum (PROS) · Breast Neoplasms (Including Advanced or Metastatic Breast Cancer With PIK3CA Mutation)
Sponsor: Cancer Research UK
Haematological Malignancy · Solid Tumour
United Kingdom
- An Ascending Dose Study of PIT565 in Participants With Rheumatoid ArthritisActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Rheumatoid Arthritis
Argentina, Bulgaria, China, France, Germany +4 more
- An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Systemic Lupus Erythematosus, SLE
China, Germany, Hungary, Netherlands, Spain +1 more
Sponsor: Novartis Pharmaceuticals
Progressive Multiple Sclerosis
Australia, Canada, France, Germany, Italy +2 more
Sponsor: Novartis Pharmaceuticals
Myeloid Leukemia, Philadelphia Positive
United States, China, France, Germany, Greece +9 more
Sponsor: Novartis Pharmaceuticals
Lupus Nephritis
Taiwan
- Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell LymphomaNot Yet Recruiting
Sponsor: Nathan Denlinger
Recurrent Diffuse Large B-Cell Lymphoma · Refractory Diffuse Large B-Cell Lymphoma
United States
- Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast CancerRecruiting
Sponsor: Novartis Pharmaceuticals
Advanced HR+/HER2- Breast Cancer
United States, Japan, Singapore
- A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseaseRecruiting
Sponsor: Novartis Pharmaceuticals
Alzheimer's Disease
United States, Australia, Canada, China, Czechia +10 more
- Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia GravisRecruiting
Sponsor: Novartis Pharmaceuticals
Generalized Myasthenia Gravis
United States, France, Japan, United Kingdom
Sponsor: Novartis Pharmaceuticals
Paroxysmal Nocturnal Hemoglobinuria · C3 Glomerulopathy
South Korea
Sponsor: Novartis Pharmaceuticals
Differentiated Thyroid Cancer (DTC)
United States, Argentina, Brazil, Canada, China +6 more